Screening Tool Identifies Older Adults With Cancer at Risk for Poor Outcomes

Ryan David Nipp, Leah L. Thompson, Brandon Temel, Charn‐Xin Fuh, Christine Server, Paul Kay, Sophia Landay, Daniel E. Lage, Lara Traeger, Erin Scott, Vicki A. Jackson, Nora Horick, Joseph A. Greer, Areej El‐Jawahri, Jennifer S. TemelJournal of the National Comprehensive Cancer Network 2020 · DOI

TL;DR

This study demonstrates that a simple, patient-reported screening tool (VES-13) can effectively identify older adults with advanced cancer who are at higher risk for poor outcomes, including increased symptom burden, greater healthcare utilization, and worse survival. Integrating such tools into routine clinical practice could help personalize care and improve outcomes for this vulnerable population.

What Problem Does This Paper Address?

As the global population ages, cancer is increasingly affecting older adults. This demographic presents unique challenges for oncologists due to complex comorbidities, functional impairments, and psychosocial issues. Identifying which older patients are most likely to experience poor health outcomes (like increased symptom burden, hospitalizations, or reduced survival) is crucial for providing timely and appropriate supportive care. However, current clinical practice often lacks systematic methods to identify these vulnerable individuals, and existing geriatric assessment tools can be time-consuming and resource-intensive. This paper aims to address this gap by evaluating a brief, patient-reported screening tool, the Vulnerable Elders Survey (VES-13), as a practical method for identifying older cancer patients at risk for adverse outcomes.

Methods

The researchers conducted a prospective, cross-sectional study involving patients aged 70 years or older diagnosed with advanced gastrointestinal cancer within the previous 8 weeks. Participants completed self-reported surveys to assess:

  • Vulnerability: Using the 13-item Vulnerable Elders Survey (VES-13). A score of 3 or higher indicated a positive screen for vulnerability.
  • Quality of Life (QoL): Using the EORTC Quality of Life of Cancer Patients questionnaire (QLQ-C30) and the EORTC Quality of Life Questionnaire-Elderly Cancer Patients module (QLQ-ELD14).
  • Symptom Burden: Using the revised Edmonton Symptom Assessment System (ESAS-r).
  • Functional Impairments: Assessing activities of daily living (ADLs), instrumental ADLs (IADLs), and number of falls. Cognitive function was assessed using the Blessed Orientation-Memory-Concentration test (BOMC).

Healthcare utilization (unplanned hospitalizations, emergency department visits) and overall survival were extracted from electronic health records. Statistical analyses, including multivariable linear regression and Cox proportional hazards regression, were used to examine the associations between vulnerability status and the various outcome measures, adjusting for relevant covariates. A false discovery rate (FDR) control method was employed to manage multiple comparisons.

Datasets

The study utilized data collected from 102 patients enrolled at Massachusetts General Hospital. This dataset included:

  • Patient-reported survey data (VES-13, QLQ-C30, QLQ-ELD14, ESAS-r, GDS-15, BOMC, ADL/IADL assessments).
  • Electronic health record data (demographics, cancer diagnosis, treatment, hospitalizations, ED visits, survival).

This study did not introduce a new benchmark dataset but rather used existing validated instruments to collect data on a specific patient population.

Key Insights and Ideas

  • VES-13 as a Practical Indicator: The study strongly supports the VES-13 as a readily implementable tool for identifying older cancer patients at risk. Its brevity and patient-reported nature make it suitable for routine clinical integration.
  • Vulnerability is Prevalent: Nearly half of the study participants screened positive for vulnerability, highlighting that this is a significant issue within the older adult cancer population.
  • Vulnerability Predicts Multiple Poor Outcomes: The findings go beyond just identifying risk; they demonstrate that vulnerability is associated with a cascade of negative outcomes, including worse QoL across multiple domains, higher symptom burden, and greater functional decline.
  • Healthcare Utilization and Survival Link: The study provides concrete evidence that vulnerable patients utilize healthcare services more (higher proportion of hospital days, increased risk of unplanned hospitalizations) and have significantly worse overall survival.
  • Clinical Implications for Treatment Decisions: The observation that vulnerable patients were less likely to receive anticancer treatment suggests that vulnerability status might already be implicitly influencing treatment decisions, underscoring the need for explicit identification and targeted supportive care.

Key Results

  • Prevalence: 45.1% of the 102 enrolled patients screened positive for vulnerability using the VES-13.
  • Demographics: Vulnerable patients were older (mean 79.45 vs 75.44 years) and had more comorbid conditions (mean 2.13 vs 1.34) compared to non-vulnerable patients.
  • Quality of Life: Vulnerable patients reported significantly worse global QoL and worse QoL across all functional domains (physical, role, emotional, cognitive, social). They also reported worse mobility, more future worries, and a higher burden of illness.
  • Symptom Burden: Vulnerable patients had substantially higher physical and total symptom burden scores on the ESAS-r. Figure 2 shows significantly higher proportions of moderate-to-severe symptoms like fatigue, drowsiness, poor well-being, and lack of appetite in the vulnerable group.
  • Functional Impairments: Vulnerable patients had significantly fewer independent ADLs and IADLs, indicating poorer physical function. They also showed higher cognitive impairment scores.
  • Healthcare Use & Survival: Vulnerable patients had a 3.56 times higher proportion of days in the hospital within 90 days (RR, 3.56; P=.006). They had a 2.38 times higher risk of unplanned hospitalizations within 90 days (HR, 2.38; P=.032) and a 2.26 times higher risk of mortality (HR, 2.26; P=.020).

Limitations and Future Work

The authors acknowledge several limitations:

  • Single Academic Center Cohort: The study was conducted at one institution, potentially limiting the generalizability of findings due to a lack of sociodemographic diversity.
  • Underestimation of Healthcare Use: Patients seeking care outside the study system might lead to an underestimation of hospitalizations and ED visits.
  • Lack of Data on Financial Burden: The study did not collect data on patients' financial burden, which can significantly impact QoL.
  • Exclusion of Patients Too Ill to Participate: Patients who felt too ill to participate might represent a particularly vulnerable subgroup, and their exclusion could bias the results.
  • Cross-Sectional Design: The study design prevents the determination of causality or the observation of how these relationships change over time.

Future research directions suggested include:

  • Longitudinal Assessments: To understand how care needs and outcomes evolve over time and in response to treatments or supportive services.
  • Intervention Development and Testing: Focusing on developing and evaluating interventions tailored to the specific geriatric and supportive care needs of vulnerable older adults with cancer.
  • Comprehensive Care Models: Emphasizing that interventions must holistically address QoL, symptom burden, and functional impairments.

Summary updated

Abstract

Older adults with cancer who screen positive as vulnerable experience a higher symptom burden, greater healthcare use, and worse survival. Screening tools to identify vulnerable patients should be integrated into practice to guide clinical care.
BibTeX
@article{nipp2020screening,
  author = {Ryan David Nipp and Leah L. Thompson and Brandon Temel and Charn‐Xin Fuh and Christine Server and Paul Kay and Sophia Landay and Daniel E. Lage and Lara Traeger and Erin Scott and Vicki A. Jackson and Nora Horick and Joseph A. Greer and Areej El‐Jawahri and Jennifer S. Temel},
  title = {{Screening Tool Identifies Older Adults With Cancer at Risk for Poor Outcomes}},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2020},
  doi = {10.6004/jnccn.2019.7355},
}
Figure